BR9712819A - Compostos tricìclicos úteis para inibição de função de proteìna g e para tratamento de doenças proliferativas - Google Patents

Compostos tricìclicos úteis para inibição de função de proteìna g e para tratamento de doenças proliferativas

Info

Publication number
BR9712819A
BR9712819A BR9712819-8A BR9712819A BR9712819A BR 9712819 A BR9712819 A BR 9712819A BR 9712819 A BR9712819 A BR 9712819A BR 9712819 A BR9712819 A BR 9712819A
Authority
BR
Brazil
Prior art keywords
function
proliferative diseases
compounds useful
treating proliferative
inhibiting protein
Prior art date
Application number
BR9712819-8A
Other languages
English (en)
Inventor
Dinanath F Rane
Alan K Mallams
Arthur G Taveras
F George Njoroge
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of BR9712819A publication Critical patent/BR9712819A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom

Abstract

Patente de Invenção:<B>"COMPOSTOS TRICìCLICOS úTEIS PARA INIBIçãO DE FUNçãO DE PROTEìNA G E PARA TRATAMENTO DE DOENçAS PROLIFERATIVAS"<D>. Compostos de fórmula (1,0), seus empregos como inibidores de proteína de transferase de farnesil e composições farmacêuticas, contendo-os são descritos, especialmente compostos de fórmula 1,5A), onde R^ 1^, R^ 2^ e R^ 3^ são halo. A e B são cada H~ 2~, e R é como definido na especificação.
BR9712819-8A 1996-09-13 1997-09-11 Compostos tricìclicos úteis para inibição de função de proteìna g e para tratamento de doenças proliferativas BR9712819A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US71332696A 1996-09-13 1996-09-13
PCT/US1997/015900 WO1998011096A1 (en) 1996-09-13 1997-09-11 Tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Publications (1)

Publication Number Publication Date
BR9712819A true BR9712819A (pt) 1999-11-23

Family

ID=24865700

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9712819-8A BR9712819A (pt) 1996-09-13 1997-09-11 Compostos tricìclicos úteis para inibição de função de proteìna g e para tratamento de doenças proliferativas

Country Status (21)

Country Link
EP (1) EP0927178B1 (pt)
JP (1) JP3152438B2 (pt)
KR (1) KR20000036059A (pt)
CN (1) CN1237169A (pt)
AT (1) ATE213736T1 (pt)
AU (1) AU729810B2 (pt)
BR (1) BR9712819A (pt)
CA (1) CA2264569C (pt)
CZ (1) CZ83499A3 (pt)
DE (1) DE69710741T2 (pt)
ES (1) ES2169420T3 (pt)
HK (1) HK1018267A1 (pt)
HU (1) HUP9904067A2 (pt)
ID (1) ID22045A (pt)
IL (1) IL128949A0 (pt)
NO (1) NO991230L (pt)
NZ (1) NZ334340A (pt)
PL (1) PL332240A1 (pt)
SK (1) SK33199A3 (pt)
TR (1) TR199900561T2 (pt)
WO (1) WO1998011096A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1047675A1 (en) 1998-01-21 2000-11-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6613905B1 (en) 1998-01-21 2003-09-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
ID26618A (id) 1998-01-21 2001-01-25 Millennium Pharm Inc Antagonis-antagonis reseptor kemokin dan metode penggunaannya
US6509346B2 (en) 1998-01-21 2003-01-21 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7271176B2 (en) 1998-09-04 2007-09-18 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use thereof
US6288083B1 (en) 1998-09-04 2001-09-11 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US6503926B2 (en) 1998-09-04 2003-01-07 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
US7541365B2 (en) 2001-11-21 2009-06-02 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
TWI291467B (en) 2002-11-13 2007-12-21 Millennium Pharm Inc CCR1 antagonists and methods of use therefor
EP1656156A2 (en) 2003-08-13 2006-05-17 Children's Hospital Medical Center Mobilization of hematopoietic cells
DK1896421T3 (da) 2005-06-23 2012-01-09 Merck Sharp & Dohme Benzocyclohetapyridiner som hæmmere af receptoren tyrosinkinase MET
TW200813021A (en) 2006-07-10 2008-03-16 Merck & Co Inc Tyrosine kinase inhibitors
TW201024283A (en) * 2008-12-01 2010-07-01 Targacept Inc Synthesis and novel salt forms of (R)-3-((E)-2-(pyrrolidin-3-yl)vinyl)-5-(tetrahydropyran-4-yloxy)pyridine
WO2018060689A1 (en) 2016-09-27 2018-04-05 Mission Therapeutics Limited Cyanopyrrolidine derivatives with activity as inhibitors of usp30

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111235A (en) * 1993-10-15 2001-03-19 Schering Plough Corp Medicinal preparations for inhibiting protein G activity and for the treatment of malignant diseases, containing tricyclic compounds, some such new compounds and a process for the preparation of some of them
IL111258A0 (en) * 1993-10-15 1994-12-29 Schering Corp Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases
WO1995010514A1 (en) * 1993-10-15 1995-04-20 Schering Corporation Tricyclic sulfonamide compounds useful for inhibition of g-protein function and for treatment of proliferative diseases

Also Published As

Publication number Publication date
IL128949A0 (en) 2000-02-17
SK33199A3 (en) 1999-12-10
ATE213736T1 (de) 2002-03-15
KR20000036059A (ko) 2000-06-26
DE69710741D1 (de) 2002-04-04
WO1998011096A1 (en) 1998-03-19
HUP9904067A2 (hu) 2000-05-28
HK1018267A1 (en) 1999-12-17
CN1237169A (zh) 1999-12-01
CZ83499A3 (cs) 1999-07-14
NZ334340A (en) 2000-09-29
TR199900561T2 (xx) 1999-06-21
NO991230L (no) 1999-05-14
NO991230D0 (no) 1999-03-12
PL332240A1 (en) 1999-08-30
EP0927178A1 (en) 1999-07-07
ES2169420T3 (es) 2002-07-01
JP3152438B2 (ja) 2001-04-03
AU729810B2 (en) 2001-02-08
DE69710741T2 (de) 2002-10-24
CA2264569C (en) 2003-11-11
EP0927178B1 (en) 2002-02-27
JP2000502727A (ja) 2000-03-07
CA2264569A1 (en) 1998-03-19
AU4337397A (en) 1998-04-02
ID22045A (id) 1999-08-26

Similar Documents

Publication Publication Date Title
BR9712831A (pt) Inibidores tricìclicos de farnesil proteìna transferase
BR9712819A (pt) Compostos tricìclicos úteis para inibição de função de proteìna g e para tratamento de doenças proliferativas
BR9714082A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto.
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
BR9709959A (pt) Derivados tricìclicos de fenilamino substituìdo para o tratamento de doenças hiperproliferativas
MY119987A (en) Antithrombotic agents.
FI945706A (fi) Proteiinikinaasi C-inhibiittoreita
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
WO1994026723A3 (en) ras FARNESYL TRANSFERASE INHIBITORS
BR9901491A (pt) 7-hetero-biciclo [2.2.1] - heptanos.
NO304884B1 (no) 9-[(substituerte glycyl)amido]-6-demetyl-6-deoksotetracykliner, og medisinske preparater derav
BR9807508A (pt) Inibidores de sulfamida da metaloprotease
ATE231872T1 (de) Thiazolopyrimidinderivate
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
HUP0203054A3 (en) Farnesyl protein transferase inhibitors, pharmaceutical compositions containing them and their use
HUP0102714A3 (en) Tricyclic sulfonamid derivatives as inhibitors of matrix metalloproteinases and medicaments containing the same
HUP0302942A3 (en) Tricyclic antitumor compounds being farnesyl protein transferase inhibitors, their use and pharmaceutical compositions containing them
DE69911785D1 (de) Triazolo[4,5-d]pyrimidin-verbindungen
BR9902347A (pt) Azabiciclos como inibidores de rotomase
BR0000901A (pt) Derivados 4-fenil-4-heteroarilpiperidina
NO990322L (no) Farmas°ytisk blanding inneholdende en 5HT2c-antagonist og en D2-antagonist
LV12375A (lv) 1-(3-aminoindazol-5-il)-fenilmetil)-cikliskas urinvielas piemerotas ka HIV proteazes inhibitori
BR9712035A (pt) Compostos Úteis para inibi-Æo de transferase de prote¡na farnesila

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]